The world pharmaceutical market is changing. In spite of the strong pricing environment for drugs in the pharma market, the change in dynamics of the pharma market & prescribing preferences has cemented the road for a much-more beneficial functioning environment for MNCs' (multi national companies). The developed pharma markets of the world are suffering from an augmented generic pressure & a drive led by health funders to control drug costs. On the other hand, the brisk appearance of developing nations as value- based markets is making the whole pharma industry to significantly re-evaluate medium and long-term policies. A continuous and strong demand for novel therapies is fueling the growth of US pharmaceutical market. Is the world's fastest growing pharmac View the rest of this article
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment